MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ajpath.2024.06.008

Медицинская библиотека · The American journal of pathology · 2024

Cardiac Atrophy, Dysfunction, and Metabolic Impairments: A Cancer-Induced Cardiomyopathy Phenotype.

Ogilvie Leslie M, Delfinis Luca J, Coyle-Asbil Bridget, Vudatha Vignesh, Alshamali Razan, Garlisi Bianca, Pereira Madison, Matuszewska Kathy, Garibotti Madison C, Gandhi Shivam, Brunt Keith R, Wood Geoffrey A, Trevino Jose G, Perry Christopher G R, Petrik Jim, Simpson Jeremy A

СтатьяПеревод в очереди

Аннотация

Muscle atrophy and weakness are prevalent features of cancer. Although extensive research has characterized skeletal muscle wasting in cancer cachexia, limited studies have investigated how cardiac structure and function are affected by therapy-naive cancer. Herein, orthotopic, syngeneic models of epithelial ovarian cancer and pancreatic ductal adenocarcinoma, and a patient-derived pancreatic xenograft model, were used to define the impact of malignancy on cardiac structure, function, and metabolism. Tumor-bearing mice developed cardiac atrophy and intrinsic systolic and diastolic dysfunction, with arterial hypotension and exercise intolerance. In hearts of ovarian tumor-bearing mice, fatty acid-supported mitochondrial respiration decreased, and carbohydrate-supported respiration increased-showcasing a substrate shift in cardiac metabolism that is characteristic of heart failure. Epithelial ovarian cancer decreased cytoskeletal and cardioprotective gene expression, which was paralleled by down-regulation of transcription factors that regulate cardiomyocyte size and function. Patient-derived pancreatic xenograft tumor-bearing mice show altered myosin heavy chain isoform expression-also a molecular phenotype of heart failure. Markers of autophagy and ubiquitin-proteasome system were upregulated by cancer, providing evidence of catabolic signaling that promotes cardiac wasting. Together, two cancer types were used to cross-validate evidence of the structural, functional, and metabolic cancer-induced cardiomyopathy, thus providing translational evidence that could impact future medical management strategies for improved cancer recovery in patients.

Для цитирования: Ogilvie Leslie M, Delfinis Luca J, Coyle-Asbil Bridget, Vudatha Vignesh, Alshamali Razan, Garlisi Bianca, Pereira Madison, Matuszewska Kathy, Garibotti Madison C, Gandhi Shivam, Brunt Keith R, Wood Geoffrey A, Trevino Jose G, Perry Christopher G R, Petrik Jim, Simpson Jeremy A. Cardiac Atrophy, Dysfunction, and Metabolic Impairments: A Cancer-Induced Cardiomyopathy Phenotype.. The American journal of pathology. 2024. DOI: 10.1016/j.ajpath.2024.06.008.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.